Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 1988 May;78(5):564–566. doi: 10.2105/ajph.78.5.564

Non-contraceptive estrogen use and the risk of gallstone disease in women.

F Kakar 1, N S Weiss 1, S A Strite 1
PMCID: PMC1349340  PMID: 3354741

Abstract

We interviewed 102 women, ages 41-74 years who underwent gallstone surgery between January 1979 and September 1980, and 98 controls selected from the membership files of a large prepaid health care plan in Western Washington, about their past use of certain medications, reproductive history, and physical and demographic characteristics. The risk of gallstone disease among women who used estrogens for at least one year prior to diagnosis of their condition, relative to that of other women, was 1.18 (95% CI: 0.65-2.13). Standardization for the effects of age, race, obesity, parity, thiazide use, and history of high blood pressure did not alter appreciably the estimate of relative risk. Among estrogen users, the duration of use was similar in cases and controls. Our findings suggest that if non-contraceptive estrogen use is a risk factor for gallstone disease (requiring surgery) in women, its effect is very small.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennion L. J. Changes in bile lipids accompanying oophorectomy in a premenopausal woman. N Engl J Med. 1977 Sep 29;297(13):709–711. doi: 10.1056/NEJM197709292971308. [DOI] [PubMed] [Google Scholar]
  2. Bennion L. J., Drobny E., Knowler W. C., Ginsberg R. L., Garnick M. B., Adler R. D., Duane W. C. Sex differences in the size of bile acid pools. Metabolism. 1978 Aug;27(8):961–969. doi: 10.1016/0026-0495(78)90140-3. [DOI] [PubMed] [Google Scholar]
  3. Bennion L. J., Ginsberg R. L., Gernick M. B., Bennett P. H. Effects of oral contraceptives on the gallbladder bile of normal women. N Engl J Med. 1976 Jan 22;294(4):189–192. doi: 10.1056/NEJM197601222940403. [DOI] [PubMed] [Google Scholar]
  4. Heuman R., Larsson-Cohn U., Hammar M., Tiselius H. G. Effects of postmenopausal ethinylestradiol treatment on gallbladder bile. Maturitas. 1980 Jan;2(1):69–72. doi: 10.1016/0378-5122(80)90062-6. [DOI] [PubMed] [Google Scholar]
  5. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  6. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976 Feb;103(2):226–235. doi: 10.1093/oxfordjournals.aje.a112220. [DOI] [PubMed] [Google Scholar]
  7. Nachtigall L. E., Nachtigall R. H., Nachtigall R. D., Beckman E. M. Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol. 1979 Jul;54(1):74–79. doi: 10.1097/00006250-197907000-00017. [DOI] [PubMed] [Google Scholar]
  8. Scragg R. K., McMichael A. J., Seamark R. F. Oral contraceptives, pregnancy, and endogenous oestrogen in gall stone disease--a case-control study. Br Med J (Clin Res Ed) 1984 Jun 16;288(6433):1795–1799. doi: 10.1136/bmj.288.6433.1795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Weiss N. S., Ure C. L., Ballard J. H., Williams A. R., Daling J. R. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med. 1980 Nov 20;303(21):1195–1198. doi: 10.1056/NEJM198011203032102. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES